SAB Biotherapeutics (SABS) Insider Trading & Ownership $1.49 -0.06 (-3.81%) As of 03/28/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SAB Biotherapeutics (NASDAQ:SABS) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage26.46%Number OfInsiders Buying(Last 3 Years)4Amount OfInsider Buying(Last 3 Years)$23,121.20Number OfInsiders Selling(Last 3 Years)0 Get SABS Insider Trade Alerts Want to know when executives and insiders are buying or selling SAB Biotherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SABS Insider Buying and Selling by Quarter Remove Ads SAB Biotherapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/7/2023Eddie Joe SullivanCEOBuy1,740$0.88$1,531.20 11/30/2023Michael KingCFOBuy5,000$0.90$4,500.00 11/29/2023Samuel J ReichChairmanBuy11,000$0.89$9,790.00 9/13/2022Christine E HamiltonDirectorBuy10,000$0.73$7,300.00 (Data available from 1/1/2013 forward) SABS Insider Trading Activity - Frequently Asked Questions Who is on SAB Biotherapeutics's Insider Roster? The list of insiders at SAB Biotherapeutics includes Christine E Hamilton, Eddie Joe Sullivan, Michael King, and Samuel J Reich. Learn more on insiders at SABS. What percentage of SAB Biotherapeutics stock is owned by insiders? 26.46% of SAB Biotherapeutics stock is owned by insiders. Learn more on SABS's insider holdings. Which SAB Biotherapeutics insiders have been buying company stock? The following insiders have purchased SABS shares in the last 24 months: Eddie Joe Sullivan ($1,531.20), Michael King ($4,500.00), and Samuel J Reich ($9,790.00). How much insider buying is happening at SAB Biotherapeutics? Insiders have purchased a total of 17,740 SABS shares in the last 24 months for a total of $15,821.20 bought. SAB Biotherapeutics Key ExecutivesMr. Samuel J. Reich (Age 49)CEO & Executive Chairman Compensation: $363.2kDr. Eddie Joe Sullivan Ph.D. (Age 57)Co-Founder, President & Director Compensation: $402.56kMs. Christine E. Hamilton M.B.A. (Age 68)Co-Founder & Independent Director Compensation: $25kMr. Michael George King Jr. (Age 63)EVP & CFO Compensation: $60.58kDr. Christoph Bausch M.B.A. (Age 53)Ph.D., Executive VP & COO Compensation: $443.2kDr. Alexandra Kropotova M.B.A. (Age 51)M.D., Executive VP & Chief Medical Officer Compensation: $774.45kDr. Edward D. Hamilton D.V.M.Co-Founder & Board ObserverDr. Carlos N. Carillo Ph.D.Senior Vice President of Regulatory Affairs More Insider Trading Tools from MarketBeat Related Companies FBIO Insider Trading AGEN Insider Trading BOLT Insider Trading MTEM Insider Trading AMGN Insider Trading GILD Insider Trading VRTX Insider Trading REGN Insider Trading ALNY Insider Trading BIIB Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles NVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish 3 Companies Buying Back Stock—Why It Matters This page (NASDAQ:SABS) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredWall Street’s “AI Oracle” Reveals Next Big Tech PlayA tiny American tech company could be at the center of the next big AI breakthrough. Wall Street's "AI Orac...InvestorPlace | SponsoredElon’s ‘Strike Squad’ sends these 9 stocks soaring?Elon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the ...Altimetry | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | SponsoredMan Who Predicted 2008 Crash: “Move your money out of stocks TODAY”Could the recent tech sell-off indicate a looming market crash? Nvidia dropped 30% from its high... Pala...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SAB Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SAB Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SABS Stock Free SABS Stock Alerts